249
Views
158
CrossRef citations to date
0
Altmetric
Original Article

Overexpression of glutathione S-transferase π enhances the adduct formation of cisplatin with glutathione in human cancer cells

, , , , &
Pages 549-558 | Received 19 Mar 1999, Published online: 07 Jul 2009
 

Abstract

In this paper, we provide direct evidence that glutathione S-transferase π (GSTπ) detoxifies cisplatin (CDDP). We used human colonic cancer HCT8 cells sensitive and resistant to CDDP, the level of cisplatin-glutathione adduct (DDP-GSH) being higher in the resistant cells. There was an overexpression of GSTπ mRNA in these CDDP-resistant cells. Incubation of the cells with CDDP resulted in the formation of DDP-GSH dependent on the CDDP concentration and the incubation time. The formation of DDP-GSH was abolished when the cells were pre-treated with ethacrynic acid or ketoprofen, inhibitors of GSTπ. Purified GSTπ also catalyzed the formation of DDP-GSH in vitro, with an apparent Km of 0.23 mM for CDDP and an apparent Vmax of 4.9 nmol/min/mg protein. The increase in DDP-GSH produced by GSTπ was linear with incubation time up to 3 h and optimal of pH 7.4. A GSTπ transfectant cell line was constructed in HCT8 cells using a pcDNA3.1 (-)/Myc-His B with an expression vector containing cDNA for GSTπ. Transfection of GSTπ cDNA into HCT8 cells resulted in an increase in the expression of GSTπ by 1.4-fold in parallel with an augmentation of the formation of DDP-GSH. These results suggest that GSTπ plays a role in the formation of DDP-GSH and the acquisition of resistance to CDDP in cancer cells.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.